Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Durkin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Lancet (London, England)|April 6, 2017
Health care must mean safe care: enshrining patient safety in global healthKelsey Flott, Gianluca Fontana, Neelam Dhingra-Kumar, et al.
BMJ Open Quality|May 8, 2024
Regional perspectives on patient safety policies and initiatives: a focus group study with patient safety leaders in the Middle East and Asian regionsNiki O'Brien, Marium Soomro, Alexandra Shaw, et al.
Early Intervention in Psychiatry|December 15, 2018
Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophreniaMarcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, et al.
Current Medical Research and Opinion|January 10, 2020
Costs associated with renal and cardiovascular events among patients with type 2 diabetes mellitus and nephropathy: a cost model based on the CREDENCE clinical trialAmeur M Manceur, Mike Durkin, Akshay Kharat, et al.
Administration and Policy in Mental Health|November 21, 2019
The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early SchizophreniaMarcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, et al.
Future Oncology (London, England)|November 3, 2021
Medication adherence among patients with advanced prostate cancer using oral therapiesDominic Pilon, Joyce LaMori, Carmine Rossi, et al.
Future Oncology (London, England)|October 5, 2022
Early prostate-specific antigen response among Black and non-Black patients with advanced prostate cancer treated with apalutamideVincent M Bivins, Mike Durkin, Ibrahim Khilfeh, et al.
Journal of Medical Economics|December 22, 2018
Economic modelling of costs associated with outcomes reported for type 2 diabetes mellitus (T2DM) patients in the CANVAS and EMPA-REG cardiovascular outcomes trialsRhiannon Kamstra, Mike Durkin, Jennifer Cai, et al.
American Health & Drug Benefits|December 21, 2016
Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with SchizophreniaMarie-Hélène Lafeuille, Christian Frois, Michel Cloutier, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Lancet (London, England)|April 6, 2017
Health care must mean safe care: enshrining patient safety in global healthKelsey Flott, Gianluca Fontana, Neelam Dhingra-Kumar, et al.
BMJ Open Quality|May 8, 2024
Regional perspectives on patient safety policies and initiatives: a focus group study with patient safety leaders in the Middle East and Asian regionsNiki O'Brien, Marium Soomro, Alexandra Shaw, et al.
Early Intervention in Psychiatry|December 15, 2018
Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophreniaMarcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, et al.
Current Medical Research and Opinion|January 10, 2020
Costs associated with renal and cardiovascular events among patients with type 2 diabetes mellitus and nephropathy: a cost model based on the CREDENCE clinical trialAmeur M Manceur, Mike Durkin, Akshay Kharat, et al.
Administration and Policy in Mental Health|November 21, 2019
The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early SchizophreniaMarcela Horvitz-Lennon, Zachary Predmore, Patrick Orr, et al.
Future Oncology (London, England)|November 3, 2021
Medication adherence among patients with advanced prostate cancer using oral therapiesDominic Pilon, Joyce LaMori, Carmine Rossi, et al.
Future Oncology (London, England)|October 5, 2022
Early prostate-specific antigen response among Black and non-Black patients with advanced prostate cancer treated with apalutamideVincent M Bivins, Mike Durkin, Ibrahim Khilfeh, et al.
Journal of Medical Economics|December 22, 2018
Economic modelling of costs associated with outcomes reported for type 2 diabetes mellitus (T2DM) patients in the CANVAS and EMPA-REG cardiovascular outcomes trialsRhiannon Kamstra, Mike Durkin, Jennifer Cai, et al.
American Health & Drug Benefits|December 21, 2016
Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with SchizophreniaMarie-Hélène Lafeuille, Christian Frois, Michel Cloutier, et al.
Pageof 2